What is Excite Pharma Services?
Excite Pharma Services operates as a premier Contract Development and Manufacturing Organization (CDMO) and Contract Research Organization (CRO), headquartered in Lees Summit, Missouri. The company serves as a critical partner for pharmaceutical enterprises, offering a comprehensive suite of services that bridge the gap between early-stage research and commercial-scale production. By maintaining rigorous adherence to FDA, cGMP, and GLP standards, Excite Pharma ensures that its clients navigate the complex regulatory landscape with precision. Their core competencies include advanced chemistry services and manufacturing excellence, positioning them as a vital link in the global drug development supply chain. The firm's ability to provide end-to-end support makes it an essential asset for companies looking to outsource complex technical requirements while maintaining strict quality control.
How much funding has Excite Pharma Services raised?
Excite Pharma Services has raised a total of $461K across 2 funding rounds:
Debt
$150K
Debt
$311K
Debt (2020): $150K with participation from PPP
Debt (2021): $311K led by PPP
Key Investors in Excite Pharma Services
PPP
Public-Private Partnership
What's next for Excite Pharma Services?
With the recent capital infusion, Excite Pharma Services is well-positioned to accelerate its late-stage growth strategy. The company is expected to focus on expanding its manufacturing capacity and enhancing its research capabilities to accommodate a broader portfolio of pharmaceutical clients. By leveraging this recent financing, the firm aims to optimize its operational efficiency and further integrate its CDMO and CRO service offerings. Future strategic initiatives will likely prioritize the adoption of advanced analytical technologies and the scaling of its facility footprint to maintain its competitive edge in the pharmaceutical services market. As the industry continues to demand higher standards of compliance and technical agility, Excite Pharma is prepared to capitalize on these trends to drive long-term value for its stakeholders.
See full Excite Pharma Services company page
